RGNX – REGENXBIO Inc.
Float Short %
11.98
Margin Of Safety %
Put/Call OI Ratio
0.77
EPS Next Q Diff
1.8
EPS Last/This Y
2.46
EPS This/Next Y
-0.26
Price
9.02
Target Price
31.31
Analyst Recom
1.38
Performance Q
-8.62
Relative Volume
1.63
Beta
1.17
Ticker: RGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | RGNX | 8.96 | 0.56 | 0.00 | 3612 |
| 2025-07-28 | RGNX | 8.79 | 0.55 | 0.00 | 3637 |
| 2025-07-29 | RGNX | 8.43 | 0.55 | 0.69 | 3655 |
| 2025-07-30 | RGNX | 8.75 | 0.55 | 0.07 | 3679 |
| 2025-07-31 | RGNX | 8.5 | 0.54 | 0.00 | 3693 |
| 2025-08-01 | RGNX | 8.18 | 0.54 | 6.60 | 3705 |
| 2025-08-04 | RGNX | 8.33 | 0.57 | 1.00 | 3808 |
| 2025-08-05 | RGNX | 8.28 | 0.57 | 0.00 | 3808 |
| 2025-08-06 | RGNX | 8.23 | 0.57 | 0.00 | 3810 |
| 2025-08-07 | RGNX | 7.89 | 0.57 | 0.52 | 3819 |
| 2025-08-08 | RGNX | 7.85 | 0.57 | 999.99 | 4022 |
| 2025-08-11 | RGNX | 7.47 | 0.58 | 1.38 | 4053 |
| 2025-08-12 | RGNX | 8.11 | 0.59 | 0.05 | 4085 |
| 2025-08-13 | RGNX | 8.93 | 0.61 | 0.04 | 4022 |
| 2025-08-14 | RGNX | 9.07 | 0.60 | 999.99 | 4055 |
| 2025-08-15 | RGNX | 8.82 | 0.60 | 0.24 | 4056 |
| 2025-08-18 | RGNX | 8.72 | 0.60 | 1.24 | 3607 |
| 2025-08-19 | RGNX | 8.04 | 0.61 | 6.82 | 3671 |
| 2025-08-20 | RGNX | 8.06 | 0.75 | 1.22 | 4020 |
| 2025-08-21 | RGNX | 8.1 | 0.77 | 0.25 | 4072 |
| 2025-08-22 | RGNX | 9.01 | 0.77 | 2.86 | 4074 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | RGNX | 8.96 | -0.4 | 219.4 | 0.23 |
| 2025-07-28 | RGNX | 8.76 | -0.4 | 218.6 | 0.23 |
| 2025-07-29 | RGNX | 8.41 | -0.4 | 215.4 | 0.23 |
| 2025-07-30 | RGNX | 8.75 | -0.4 | 227.6 | 0.23 |
| 2025-07-31 | RGNX | 8.51 | -0.4 | 217.7 | 0.23 |
| 2025-08-01 | RGNX | 8.19 | -0.4 | 216.1 | 0.23 |
| 2025-08-04 | RGNX | 8.33 | -0.4 | 224.4 | 0.23 |
| 2025-08-05 | RGNX | 8.29 | -0.4 | 221.0 | 0.23 |
| 2025-08-06 | RGNX | 8.23 | -0.4 | 220.6 | 0.23 |
| 2025-08-07 | RGNX | 7.90 | -0.4 | 215.6 | 0.23 |
| 2025-08-08 | RGNX | 7.85 | -0.4 | 220.9 | 0.23 |
| 2025-08-11 | RGNX | 7.46 | -0.4 | 218.5 | 0.23 |
| 2025-08-12 | RGNX | 8.07 | -5.0 | 248.8 | 0.23 |
| 2025-08-13 | RGNX | 8.93 | -5.0 | 251.0 | 0.23 |
| 2025-08-14 | RGNX | 9.06 | -5.0 | 110.4 | 0.23 |
| 2025-08-15 | RGNX | 8.82 | -5.0 | 113.5 | -2.03 |
| 2025-08-18 | RGNX | 8.72 | -10.2 | 112.4 | -2.03 |
| 2025-08-19 | RGNX | 8.03 | -10.2 | 117.6 | -2.03 |
| 2025-08-20 | RGNX | 8.07 | -10.2 | 111.1 | -2.03 |
| 2025-08-21 | RGNX | 8.09 | -10.2 | 111.3 | -2.03 |
| 2025-08-22 | RGNX | 9.02 | -10.2 | 102.0 | -2.13 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | RGNX | -0.43 | -8.77 | 13.53 |
| 2025-07-28 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-07-29 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-07-30 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-07-31 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-08-01 | RGNX | -0.43 | -1.53 | 13.53 |
| 2025-08-04 | RGNX | -0.43 | -1.27 | 13.53 |
| 2025-08-05 | RGNX | -0.43 | -1.27 | 13.53 |
| 2025-08-06 | RGNX | -0.43 | -1.27 | 13.53 |
| 2025-08-07 | RGNX | -0.43 | -1.27 | 13.53 |
| 2025-08-08 | RGNX | -0.43 | -1.27 | 13.53 |
| 2025-08-11 | RGNX | -0.43 | -1.55 | 13.50 |
| 2025-08-12 | RGNX | -0.43 | -1.55 | 11.98 |
| 2025-08-13 | RGNX | -0.43 | -1.55 | 11.98 |
| 2025-08-14 | RGNX | -0.43 | -1.55 | 11.98 |
| 2025-08-15 | RGNX | -0.43 | -1.55 | 11.98 |
| 2025-08-18 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-19 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-20 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-21 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-22 | RGNX | -0.43 | -6.12 | 11.98 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.38
Avg. EPS Est. Current Quarter
-1.29
Avg. EPS Est. Next Quarter
0.42
Insider Transactions
-0.43
Institutional Transactions
-6.12
Beta
1.17
Average Sales Estimate Current Quarter
24
Average Sales Estimate Next Quarter
95
Fair Value
Quality Score
41
Growth Score
39
Sentiment Score
2
Actual DrawDown %
82.1
Max Drawdown 5-Year %
-89.4
Target Price
31.31
P/E
Forward P/E
PEG
P/S
2.92
P/B
2.12
P/Free Cash Flow
EPS
-3.46
Average EPS Est. Cur. Y
-2.13
EPS Next Y. (Est.)
-2.39
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-112.7
Relative Volume
1.63
Return on Equity vs Sector %
-106.9
Return on Equity vs Industry %
-93.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-2.36
EBIT Estimation
102
REGENXBIO Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 353
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading